mutLBSgeneDB |
Gene summary for CHIA |
Gene summary |
Basic gene Info. | Gene symbol | CHIA |
Gene name | chitinase, acidic | |
Synonyms | AMCASE|CHIT2|TSA1902 | |
Cytomap | UCSC genome browser: 1p13.2 | |
Type of gene | protein-coding | |
RefGenes | NM_001040623.2, NM_001258001.1,NM_001258002.1,NM_001258003.1,NM_001258004.1, NM_001258005.1,NM_021797.3,NM_201653.3, | |
Description | acidic mammalian chitinaselung-specific protein TSA1902 | |
Modification date | 20141207 | |
dbXrefs | MIM : 606080 | |
HGNC : HGNC | ||
Ensembl : ENSG00000134216 | ||
HPRD : 09355 | ||
Vega : OTTHUMG00000011165 | ||
Protein | UniProt: Q9BZP6 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CHIA | |
BioGPS: 27159 | ||
Pathway | NCI Pathway Interaction Database: CHIA | |
KEGG: CHIA | ||
REACTOME: CHIA | ||
Pathway Commons: CHIA | ||
Context | iHOP: CHIA | |
ligand binding site mutation search in PubMed: CHIA | ||
UCL Cancer Institute: CHIA | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0002532 | production of molecular mediator involved in inflammatory response | 18824549 | GO:0006032 | chitin catabolic process | 19435888 | GO:0090197 | positive regulation of chemokine secretion | 18824549 |
Top |
Ligand binding site mutations for CHIA |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) : non-synonymous mutation on LBS, Circle size denotes number of samples. |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | D213 | L214I | COAD | 1 | Y267 | P265T | KIRC | 1 | I300 | G299W | LUAD | 1 | D138 | D136Y | LUAD | 1 | W31 | A32D | PRAD | 1 | W218 | G220S | SKCM | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for CHIA |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | D213 | L214I | -1.5397806 | W218 | G220S | -1.3921553 | W31 | A32D | -0.74305762 | Y267 | P265T | -0.55228355 | D138 | D136Y | -0.14055917 | I300 | G299W | -0.08332387 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for CHIA from PDB |
Top |
Differential gene expression and gene-gene network for CHIA |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for CHIA |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0000786 | Abortion, Spontaneous | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for CHIA |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of CHIA go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | AMI | ALLOSAMIZOLINE | 3fy1 | A | D138 D213 Y267 | AMI | ALLOSAMIZOLINE | 3fy1 | B | D138 D213 Y267 | 3RM | 5-{4-[2-(4-BROMOPHENOXY)ETHYL]PIPERAZIN-1-YL}-4H-1,2,4-TRIAZOL-3-AMINE | 3rm4 | A | D138 D213 Y267 I300 | 3RM | 5-{4-[2-(4-BROMOPHENOXY)ETHYL]PIPERAZIN-1-YL}-4H-1,2,4-TRIAZOL-3-AMINE | 3rm4 | B | D138 D213 Y267 I300 | RM8 | 2-METHYL-3-{[4-(PYRIDIN-2-YL)PIPERAZIN-1-YL]METHYL}-1H-INDOLE | 3rm8 | A | D138 D213 Y267 I300 | RM8 | 2-METHYL-3-{[4-(PYRIDIN-2-YL)PIPERAZIN-1-YL]METHYL}-1H-INDOLE | 3rm8 | B | D138 D213 Y267 I300 | DW0 | BISDIONIN C | 2ybt | C | D213 W218 | 613 | 4-(4-CHLOROPHENYL)PIPERAZINE-1-CARBOXIMIDAMIDE | 3rm9 | A | D213 Y267 I300 | 613 | 4-(4-CHLOROPHENYL)PIPERAZINE-1-CARBOXIMIDAMIDE | 3rm9 | B | D213 Y267 I300 | DW0 | BISDIONIN C | 2ybt | A | W218 | DW0 | BISDIONIN C | 2ybt | B | W218 | DW0 | BISDIONIN C | 2ybt | D | W218 | DW0 | BISDIONIN C | 2ybt | E | W218 | DW0 | BISDIONIN C | 2ybt | F | W218 | CX9 | BISDIONIN F | 2ybu | A | W218 | CX9 | BISDIONIN F | 2ybu | B | W218 | CX9 | BISDIONIN F | 2ybu | C | W218 | CX9 | BISDIONIN F | 2ybu | D | W218 | CX9 | BISDIONIN F | 2ybu | E | W218 | CX9 | BISDIONIN F | 2ybu | F | W218 | NA1 | 2-(ACETYLAMINO)-2-DEOXY-6-O-METHYL-ALPHA-D-ALLOPYRANOSE | 3fy1 | A | W31 | NA1 | 2-(ACETYLAMINO)-2-DEOXY-6-O-METHYL-ALPHA-D-ALLOPYRANOSE | 3fy1 | B | W31 | RME | NICOTINAMIDE | 3rme | A | W31 D138 D213 Y267 I300 | RME | NICOTINAMIDE | 3rme | B | W31 D138 D213 Y267 I300 | DW0 | BISDIONIN C | 2ybt | A | W31 D138 Y267 | DW0 | BISDIONIN C | 2ybt | B | W31 D138 Y267 | DW0 | BISDIONIN C | 2ybt | C | W31 D138 Y267 | DW0 | BISDIONIN C | 2ybt | D | W31 D138 Y267 | DW0 | BISDIONIN C | 2ybt | E | W31 D138 Y267 | DW0 | BISDIONIN C | 2ybt | F | W31 D138 Y267 | CX9 | BISDIONIN F | 2ybu | A | W31 D138 Y267 | CX9 | BISDIONIN F | 2ybu | B | W31 D138 Y267 | CX9 | BISDIONIN F | 2ybu | C | W31 D138 Y267 | CX9 | BISDIONIN F | 2ybu | D | W31 D138 Y267 | CX9 | BISDIONIN F | 2ybu | E | W31 D138 Y267 | CX9 | BISDIONIN F | 2ybu | F | W31 D138 Y267 |
Top |
Conservation information for LBS of CHIA |
Multiple alignments for Q9BZP6 in multiple species |
LBS | AA sequence | # species | Species | A183 | LMVTAAVAAGI | 2 | Homo sapiens, Rattus norvegicus | A183 | LLVTAAVAAGI | 1 | Bos taurus | A183 | LMVTAAVAGGI | 1 | Mus musculus | A295 | PAGPYTRQAGF | 2 | Mus musculus, Rattus norvegicus | A295 | PAGPYAKESGI | 1 | Homo sapiens | A295 | PAGPYTREAGF | 1 | Bos taurus | D138 | DGLDFDWEYPG | 2 | Homo sapiens, Bos taurus | D138 | DGLDLDWEYPG | 2 | Mus musculus, Rattus norvegicus | D213 | HVMTYDLHGSW | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | D213 | HVMTYDFHGSW | 1 | Bos taurus | E140 | LDLDWEYPGSR | 2 | Mus musculus, Rattus norvegicus | E140 | LDFDWEYPGSR | 1 | Homo sapiens | E140 | LDFDWEYPGFR | 1 | Bos taurus | E297 | GPYTRQAGFWA | 2 | Mus musculus, Rattus norvegicus | E297 | GPYAKESGIWA | 1 | Homo sapiens | E297 | GPYTREAGFWA | 1 | Bos taurus | G98 | LLAIGGWNFGT | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | I300 | TRQAGFWAYYE | 2 | Mus musculus, Rattus norvegicus | I300 | AKESGIWAYYE | 1 | Homo sapiens | I300 | TREAGFWAYYE | 1 | Bos taurus | L364 | VWAIDLDDFTG | 2 | Homo sapiens, Bos taurus | L364 | IWAIDLDDFTG | 2 | Mus musculus, Rattus norvegicus | M210 | DFIHVMTYDLH | 2 | Mus musculus, Rattus norvegicus | M210 | DYIHVMTYDLH | 1 | Homo sapiens | M210 | DFIHVMTYDFH | 1 | Bos taurus | M358 | NFGGAMIWAID | 2 | Mus musculus, Rattus norvegicus | M358 | KFGGAMVWAID | 1 | Homo sapiens | M358 | NFGGAMVWAID | 1 | Bos taurus | N100 | AIGGWNFGTAP | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | R35 | NWAQYRPGLGS | 3 | Bos taurus, Mus musculus, Rattus norvegicus | R35 | NWAQYRPGLGR | 1 | Homo sapiens | W218 | DLHGSWEGYTG | 2 | Homo sapiens, Mus musculus | W218 | DFHGSWEGYTG | 1 | Bos taurus | W218 | DLHGSWDGYTG | 1 | Rattus norvegicus | W31 | CYFTNWAQYRP | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | W31 | CYFSNWAQYRP | 1 | Bos taurus | W360 | GGAMVWAIDLD | 2 | Homo sapiens, Bos taurus | W360 | GGAMIWAIDLD | 2 | Mus musculus, Rattus norvegicus | W99 | LAIGGWNFGTA | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | Y212 | IHVMTYDLHGS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | Y212 | IHVMTYDFHGS | 1 | Bos taurus | Y267 | VGFPTYGHNFI | 1 | Homo sapiens | Y267 | IGFPAYGHNFI | 1 | Bos taurus | Y267 | VGFPEYGHTFI | 1 | Mus musculus | Y267 | VGFPEYGHTYI | 1 | Rattus norvegicus | Y27 | YQLTCYFTNWA | 1 | Homo sapiens | Y27 | YQLVCYFSNWA | 1 | Bos taurus | Y27 | YNLICYFTNWA | 1 | Mus musculus | Y27 | YNLVCYFTNWA | 1 | Rattus norvegicus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |